𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of methods trial for high-risk HPV

✍ Scribed by Daniel F. I. Kurtycz; Michele Smith; Rong He; Kayo Miyazaki; John Shalkham


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
75 KB
Volume
38
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparison of the performance of differe
✍ Stefanie J. Klug; Anco Molijn; Betti Schopp; Barbara Holz; Angelika Iftner; Wim πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract Classification of high‐risk HPV types for cervical cancer screening depends on epidemiological studies defining HPV type‐specific risk. The genotyping tests that are used, are however, not uniform with regard to type‐specific detection rates making comparisons between different studies

POBASCAM, a population-based randomized
✍ Nicole W.J. Bulkmans; Lawrence Rozendaal; Peter J.F. Snijders; Feja J. Voorhorst πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 253 KB πŸ‘ 2 views

## Abstract Cytological cervical screening is rather inefficient because of relatively high proportions of false negative and false positive smears. To evaluate the efficiency of high‐risk human papillomavirus (hrHPV) testing, by GP5+/6+ PCR‐enzyme immunoassay (EIA), in conjunction with cytology (I

HLA-B alleles, high-risk HPV infection a
✍ Paul K.S. Chan; Jo L.K. Cheung; Tak-Hong Cheung; Che-kit Lin; Ann O.Y. Tam; Deni πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 1 views

A population-based study was conducted on 256 southern Chinese with cervical intraepithelial neoplasia grade III (CIN III) or invasive cervical cancer (ICC) and on 258 controls to examine the associations between HLA-B alleles, infection with high-risk human papillomaviruses (HPVs) and the developme

Cidofovir induces an increase in levels
✍ Adam J. Donne; Lynne Hampson; Xiaotong T. He; Michael P. Rothera; Jarrod J. Home πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 335 KB

## Abstract ## __Background.__ Cidofovir is a nucleoside analogue that is used off‐license to treat recurrent respiratory papillomatosis (RRP) caused by HPV6/11. However, the effect of this drug upon low‐risk HPV 6/11 gene expression is unknown. ## __Methods.__ The expression of E6 was evaluated